1. Lund TC, Boitano AE, Delaney CS, Shpall EJ, Wagner JE. Advances in umbilical cord blood manipulation—from niche to bedside. Nat Rev Clin Oncol. 2014. doi: 10.1038/nrclinonc.2014.215 . Published online 16 December 2014.
2. Pluripotent stem cells in translation: early decisions. NIH/FDA conference. March 21–22, 2011.
3. Code of Federal Regulations, Title 45 Department of Health and Human Services Part 46: protection of human subjects. Subpart A, basic HHS policy for protection of human research subjects. Revised January 15, 2009; Effective July 14, 2009. Available from: http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html .
4. Code of Federal Regulations, Title 21 Food and Drug Administration, Department of Health and Human Services Part 50: protection of human subjects. Subpart B, informed consent of human subjects. Revised as of April 1, 2014 Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=50 .
5. Guidance for Industry E6 good clinical practice: consolidated guidance. International Conference on Harmonization (ICH) E6 Available from: http://www.fda.gov/downloads/Drugs/Guidances/ucm073122.pdf . April 1996.